Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011854 (
type 1 diabetes
)
20,749
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Human Leukocyte Antigen (HLA)-DQ2 and HLA-DQ8 are genetic risk factors for
Type 1 Diabetes Mellitus
(T1DM) and Celiac disease (CD) in Caucasians, but their association with Taiwanese Han population is unknown. We screened 532 Taiwanese T1DM patients for CD biomarkers including anti-tissue transglutaminase (
TGM2
), anti-gliadin and anti-neoepitope antibodies (Abs), sequencing DQB1 genotypes, and characterized the
TGM2
Abs. We report that 3.76% of Taiwanese patients had
TGM2
-Abs and all had no CD's symptoms. In contrast to Caucasian's CD patients, DQ2/DQ8 only constituted ~4/5 of
TGM2
-Abs positive patients, while the other ~1/5 patients belonged to different HLA genotypes. Either anti-gliadin or anti-neoepitope Abs coexisted with ~3/4 of
TGM2
-Abs positive patients that were likely due to gluten-ingestion, while the cause of
TGM2
-Abs production for other ~1/4 of patients was unknown. Purified anti-
TGM2
IgA (TGA) and anti-
TGM2
IgG (TGG) could bind on endothelial cells surface, recognized native better than denatured forms of
TGM2
, and TGA inhibited
TGM2
's transamidation activity by up to 80% but TGG had no effects. Epitope mapping of all
TGM2
-Abs positive sera demonstrated that
TGM2
-Abs had heterogeneity in specificities. This is the first study on the differences between Taiwanese Han group and Caucasian in HLA genotypes and properties of
TGM2
-Abs.
...
PMID:HLA-DQ genotype and biochemical characterization of anti-transglutaminase 2 antibodies in patients with type 1 diabetes mellitus in Taiwan. 3236 42